Logo image
Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma
Journal article   Open access   Peer reviewed

Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma

Yasser M. El-Gohary, Jan F. Silverman, Peter R. Olson, Yulin L. Liu, Jeffrey K. Cohen, Ralph Miller and Reda S. Saad
American journal of clinical pathology, v 127(4), pp 572-579
01 Apr 2007
PMID: 17369132
url
https://doi.org/10.1309/x6nxye57dlue2nq8View
Published, Version of Record (VoR)Maybe Open Access (Publisher Bronze) Open
url
https://doi.org/10.1309/X6NXYE57DLUE2NQ8View
Published, Version of Record (VoR) Open

Abstract

Life Sciences & Biomedicine Pathology Science & Technology
We studied endoglin and vascular endothelial growth factor (VEGF) expression as prognostic markers in prostatic adenocarcinoma in 50 radical prostatectomy specimens. Cases were further categorized by Gleason score as follows: 8 to 10, 9 cases; 7 (4 + 3), 9 cases; 7 (3 + 4), 14 cases; 6, 13 cases; and 4 or 5, 5 cases. All cases were immunostained for endoglin, CD31, and VEGF Positively stained microvessels were counted in densely vascular foci in a x 400 field. VEGF staining intensity was scored on a 2-tiered scale. Results were correlated with survival and other parameters. Endoglin demonstrated significantly more microvessels than did CD31 (mean +/- SD, 37 +/- 15 vs 22 +/- 17; P < .001). VEGF expression was low in 21 cases (42%) and high in 29 (58%). Endoglin correlated positively with Gleason score, lymph node metastases, tumor stage, and preoperative prostate-specific antigen level (P < .05) but not with CD31. VEGF correlated significantly with angiolymphatic invasion and Gleason score (P < .05). A high endoglin microvessel count and VEGF expression correlated with shorter survival. Endoglin is a more specific and sensitive marker for tumor angiogenesis than CD31 and may serve as a prognostic marker for prostatic adenocarcinoma.

Metrics

11 Record Views
109 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Pathology
Logo image